|
WARNING!!!!
HEART ATTACKS • STROKES • DEATH
COX-2 INHIBITORS
Estimated 20 Million People Took Drug which resulted in 100,000 + Life Threatening Injuries including Sudden Death!!!
If you or someone you know suffered injury... you must Reply NOW - Strict DEADLINE for Filing Lawsuit!
|
 Merck & Co., the makers of the prescription drug Vioxx has issued a worldwide recall because the drug may cause heart attacks and strokes.
If you've taken Vioxx within the last 3 years and suffered a heart attack or stroke, it may be the result of taking the prescription drug Vioxx.
If you or someone you know has had a stroke or heart attack after taking Vioxx - please complete our confidentional questionnaire or call our offices at Toll Free:1-888-766-2690 immediately so that we can invesitgate your situation as quickly as possible.
>>> Please Fill out our Confidential Questionnaire Form
|
Announcements
VIOXX SETTLEMENT MAY COST 5 BILLION |
| Posted by: vioxx on 11/09/2007 07:22 PM (Read: 224) |
| Merck & Co., after setting aside nothing to resolve liability over its Vioxx painkiller, may pay about $5 billion to settle claims that it hid the health risks of its withdrawn drug, three lawyers with direct knowledge of the accord said.
Merck, the third-largest U.S. drug maker, pulled Vioxx off the market in 2004 after a study showed it raised the risk of heart attacks in some patients. The company is facing more than 26,500 lawsuits filed by former users who claim the drug caused strokes and heart attacks.
|
| Read More
|
Update 2: Motion to Postpone Vioxx Trial Rejected |
| Posted by: vioxx on 08/30/2005 10:42 AM (Read: 1471) |
| Beleaguered drug maker Merck & Co.'s request to postpone the next trial over its withdrawn painkiller Vioxx was turned down Monday by the New Jersey judge presiding over the case. |
| Read More
| 3 Comments
|
Merck May Face Pressure to Settle After Vioxx Loss (Update2) |
| Posted by: vioxx on 08/22/2005 09:57 AM (Read: 1593) |
| Merck & Co.'s loss in the first trial over the painkiller Vioxx may put pressure on the company to settle 4,000 similar lawsuits as well as future claims as it prepares for the next court battle in Atlantic City, New Jersey. |
| Read More
| 0 Comments
|
A rundown of principals in the nation's first Vioxx trial |
| Posted by: vioxx on 08/20/2005 09:38 AM (Read: 1407) |
| ANGLETON, Texas -- Here is a rundown of the principal players in the nation's first Vioxx-related case to go to trial: |
| Read More
| 0 Comments
|
David Graham On The Vioxx Verdict |
| Posted by: vioxx on 08/20/2005 09:36 AM (Read: 1357) |
| No single person has come to more represent the big questions about drug safety that emerged following the withdrawal of Merck's painkiller Vioxx than the Food and Drug Administration's David Graham. |
| Read More
| 0 Comments
|
|
Leflaw.com News
Top Legal News from Leflaw.com
- VIOXX trial centers around New England Journal of Medicine article
-
A top medical journal's criticism of a study cited in Vioxx lawsuits is expected to play a part in the retrial of the first federal Vioxx lawsuit - but it's not clear if it will be a legal hand grenade or a nuclear warhead.
Updated: 2006-02-06 13:13:10
- SONY BMG Recalls 49 Titles, But "rootkit" Still Under Class action Investigation
-
contact us now!
Updated: 2005-12-28 13:38:16
- CITIGROUP'S PENSION ILLEGAL???
-
Contact us toll free at (888) 766-2690, via e-mail or by filling this form.
Updated: 2005-12-28 13:40:11
- Cash balance pension plan conversions may be discriminatory
-
View complaint filed against PNC for these practices... click here
Updated: 2005-12-28 13:40:58
- Hybrid (Cash Balance) Pension Plans Discriminatory against older workers?
-
VIEW PENSION INFORMATION FOR CORPORATIONS click here
Updated: 2005-12-27 11:01:06
- Guidant
-
An October 20, 2005, New York Times article, recapped Guidants history of selling defective defibrillators and pacemakers. The lengthy article highlights Guidants decision not to disclose its device defects to the general public or medical community, and to, moreover, continue providing defective devices to unsuspecting doctors and patients, even after they had fixed the defects in later models. With respect to the devices that had already been installed, Guidant took the position that replacement of the devices carried a higher risk from infection, than keeping the defective devices in the recipients. But Cardiologists feel that depends on the patient.
Updated: 2005-10-20 17:25:59
- iPod
-
Some owners of Apple Computer's new "impossibly small" iPod Nano are starting to wonder if the device is also impossibly delicate.
Updated: 2005-10-02 04:06:18
- Paxil
-
WASHINGTON -- The Food and Drug Administration is warning that a study has suggested that the antidepressant Paxil may be associated with birth defects.
Paxil's manufacturer, GlaxoSmithKline, said it will include the results of the study in the drug's list of precautions.
Updated: 2005-10-02 04:06:20
- Judge intervenes as second Vioxx trial heats up
-
ATLANTIC CITY, N.J. - Verbal jousting between a defense lawyer and a key plaintiff’s witness escalated Tuesday and the judge told attorneys to calm down during the second trial over Merck & Co.’s withdrawn painkiller Vioxx.
Updated: 2005-10-02 04:06:22
- Vioxx judge reprimands Merck lawyer
-
SEP. 15 8:19 P.M. ET Threatening to declare a mistrial, the judge hearing a product liability suit over painkiller Vioxx reprimanded manufacturer Merck & Co.'s lead lawyer Thursday for violating an order barring comments about lawyers in front of the jury.
Updated: 2005-10-02 04:06:23
Category: Uncategorized
Uncategorized
Uncategorized
Uncategorized
Uncategorized
More Feeds
|
Contact Us
 Lawrence E. Feldman & Associates
432 Tulpehocken Ave
Elkins Park, PA 19027
1-888-766-2690
|
|
|
| Free Consultation |
If you or someone you know has had a Stroke or Heart Attack after taking:
Vioxx Form
Bextra Form
|
| Vioxx/Bextra Forum |
Talk with others who have common concerns about the prescription drug Vioxx at :
VioxxTalk.com
Leflaw.com
|
| FDA News |
| The Food and Drug Administration (FDA) today issued a Public Health Advisory summarizing the agency's recent recommendations concerning the use of non-steroidal anti-inflammatory drug products (NSAIDs), including those known as COX-2 selective agents. The public health advisory is an interim measure, pending further review of data that continue to be collected.
|
|
